The Role of HB-EGF in Renal Epithelial Cell Injury
The Role of HB-EGF in Renal Epithelial Cell Injury
批准号:
7564739
负责人:
RAYMOND C. HARRIS
金额:
$31.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-02-15 至 2009-12-31
关键词:
AcuteAnoikisApoptosisCell CommunicationCell PolarityCell physiologyCell-Cell AdhesionCell-Matrix JunctionCellsChimera organismChronicChronic Kidney FailureDTR geneDevelopmentDistalElementsEngineeringEpidermal Growth FactorEpidermal Growth Factor ReceptorEpithelial CellsErbB4 geneGlycoproteinsGrowth FactorHeparinHeparin BindingInhibition of ApoptosisInjuryInorganic SulfatesIntegrinsInternetKidneyLeadMediatingMediationMediator of activation proteinMembraneMusMutationNatural regenerationNephronsPlayPrincipal InvestigatorProteinsRecoveryRelative (related person)ResistanceRoleScaffolding ProteinSignal PathwaySignal TransductionStructureTestingTransgenic MiceUnspecified or Sulfate Ion Sulfatesautocrinecell injurycell motilityhuman PHEMX proteinin vivooverexpressionparacrinepreventprogramsrecombinaseresponsescaffold
中文摘要
越来越多的证据表明,EGF受体(EGFR; HER1)激活在急性肾损伤后恢复中的作用。通过EGFR和HER4发出信号的肝素结合表皮生长因子(HB-EGF)在哺乳动物肾脏中对急性损伤的反应中表达增加。可溶性HB-EGF的前体是膜相关HB-EGF (proHB-EGF)。我们假设在肾上皮细胞中,proHB-EGF介导的细胞功能不同于可溶性HB-EGF。我们认为,proHBEGF通过以下途径帮助维持上皮细胞的极性、完整性和分化:1)通过EGFR和/或HER4传递近肽信号;2)作为促进细胞间相互作用的膜相关元件和细胞骨架元件(四联蛋白、整合蛋白和糖蛋白)的支架。因此,proHB-EGF的裂解可能通过释放可溶性HB-EGF(可作为自分泌和旁分泌生长因子)以及破坏proHB-EGF和相关蛋白的细胞-细胞、细胞- ecm和细胞骨架相互作用(易使上皮细胞运动、增殖和去分化)导致细胞活化。特异性目的1将研究proHBEGF激活近肽在上皮细胞-细胞相互作用中的作用。特异性目标#2将确定proHBEGF与四联蛋白-整合素网和含硫酸肝素糖蛋白相互作用在细胞-基质和细胞-细胞相互作用中的作用。特异性目的#3将研究proHB-EGF保护肾上皮细胞免受凋亡的机制。对于Specific Aims #1-3,我们将利用proHB-EGF分子的突变和嵌合体来区分EGFR激活、肝素结合、四跨蛋白相互作用和细胞质蛋白相互作用。Specific Aim #4将利用表达固定HB-EGF的小鼠与表达靶向肾单元片段特异性Cre重组酶的小鼠的杂交,以及在近端肾单元过表达HB-EGF的转基因小鼠,来研究HB-EGF表达改变对肾脏对急性和进行性损伤的反应的影响。
英文摘要
There is increasing evidence for a role for EGF receptor (EGFR; HER1) activation in recovery from acute renal injury. Expression of heparin-binding epidermal growth factor (HB-EGF), which signals through EGFR as well as HER4, increases in the mammalian kidney in response to acute injury. The precursor for soluble HB-EGF is membrane-associated HB-EGF (proHB-EGF). We hypothesize that in renal epithelial cells, proHB-EGF mediates different cellular functions than soluble HB-EGF. We propose that proHBEGF helps to maintain epithelial cell polarity, integrity and differentiation by: 1) juxtacrine signaling through EGFR and/or HER4; and 2) serving as a scaffold for membrane-associated and cytoskeletal elements (tetraspanins, integrins and glycoproteins) that promote cell-cell interactions. Therefore, cleavage of proHB-EGF may lead to cell activation by release of soluble HB-EGF that can serve as an autocrine and paracrine growth factor as well as by disruption of cell-cell, cell-ECM and cytoskeletal interactions of proHB-EGF and associated proteins that predispose the epithelial cells to motility, proliferation and dedifferentiation. Specific Aim #1 will study the role of juxtacrine activation by proHBEGF in mediation of epithelial cell-cell interactions. Specific Aim #2 will determine the role of proHBEGF's interactions with the tetraspanin-integrin web and with heparin sulfate-containing glycoproteins in mediation of cell-matrix and cell-cell interactions. Specific Aim #3 will investigate the mechanisms by which proHB-EGF protects renal epithelial cells against apoptosis. For Specific Aims #1-3, we will utilize mutations and chimeras of the proHB-EGF molecule that will discriminate among EGFR activation, heparin binding, tetraspanin interaction and cytosolic protein interactions. Specific Aim #4 will utilize crosses of mice expressing floxed HB-EGF with mice expressing targeted nephron segment specific Cre recombinase, as well as transgenic mice overexpressing HB-EGF in proximal nephron, to examine the effects of altered HB-EGF expression on kidney responses to acute and progressive injury.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of Clonal Hematopoiesis on the Progression of Kidney Disease
-
批准号:10419907
-
项目类别:
-
资助金额:$74.05万
-
财政年份:2022
-
负责人:RAYMOND C. HARRIS
-
依托单位:
Impact of Clonal Hematopoiesis on the Progression of Kidney Disease
-
批准号:10611485
-
项目类别:
-
资助金额:$71.75万
-
财政年份:2022
-
负责人:RAYMOND C. HARRIS
-
依托单位:
Organ Specific Project - Kidney
-
批准号:10201589
-
项目类别:
-
资助金额:$115.85万
-
财政年份:2018
-
负责人:RAYMOND C. HARRIS
-
依托单位:
Vanderbilt O'Brien Kidney Center-Administrative Core
-
批准号:10163163
-
项目类别:
-
资助金额:$11.66万
-
财政年份:2017
-
负责人:RAYMOND C. HARRIS
-
依托单位:
Vanderbilt O'Brien Kidney Center
-
批准号:10163162
-
项目类别:
-
资助金额:$118.5万
-
财政年份:2017
-
负责人:RAYMOND C. HARRIS
-
依托单位:
Role of Renal Macrophages in Recovery from Acute Kidney Injury
-
批准号:8504287
-
项目类别:
-
资助金额:$33.95万
-
财政年份:2013
-
负责人:RAYMOND C. HARRIS
-
依托单位:
Role of Renal Macrophages in Recovery from Acute Kidney Injury
-
批准号:8713987
-
项目类别:
-
资助金额:$34.15万
-
财政年份:2013
-
负责人:RAYMOND C. HARRIS
-
依托单位:
The Role of renal macrophages in recovery from renal injury
-
批准号:9765295
-
项目类别:
-
资助金额:$59.04万
-
财政年份:2013
-
负责人:RAYMOND C. HARRIS
-
依托单位:
Role of Renal Macrophages in Recovery from Acute Kidney Injury
-
批准号:9284449
-
项目类别:
-
资助金额:$34.37万
-
财政年份:2013
-
负责人:RAYMOND C. HARRIS
-
依托单位:
Role of Renal Macrophages in Recovery from Acute Kidney Injury
-
批准号:9067144
-
项目类别:
-
资助金额:$34.37万
-
财政年份:2013
-
负责人:RAYMOND C. HARRIS
-
依托单位:
The Role of renal macrophages in recovery from renal injury
-
批准号:10194467
-
项目类别:
-
资助金额:$59.04万
-
财政年份:2013
-
负责人:RAYMOND C. HARRIS
-
依托单位:
Role of Renal Macrophages in Recovery from Acute Kidney Injury
-
批准号:9273713
-
项目类别:
-
资助金额:$10.82万
-
财政年份:2013
-
负责人:RAYMOND C. HARRIS
-
依托单位:
Role of the innate immune system in acute kidney injury
-
批准号:10655797
-
项目类别:
-
资助金额:$63.08万
-
财政年份:2013
-
负责人:RAYMOND C. HARRIS
-
依托单位:
The Role of Cyclooxygenase-2 in Podocyte Injury in Diabetic Nephropathy
-
批准号:8391132
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:RAYMOND C. HARRIS
-
依托单位:
Mechanisms of Adaptive and Maladaptive Responses of Renal Epithelium to Injury
-
批准号:9898215
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:RAYMOND C. HARRIS
-
依托单位:
Role of P450 Metabolites in Renal Tubular Epithelial Growth and Function
-
批准号:7758890
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2009
-
负责人:RAYMOND C. HARRIS
-
依托单位:
The Role of Cyclooxygenase-2 in Podocyte Injury in Diabetic Nephropathy
-
批准号:7780070
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:RAYMOND C. HARRIS
-
依托单位:
Role of the EGF Receptor in Diabetic Nephropathy
-
批准号:8541434
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:RAYMOND C. HARRIS
-
依托单位:
Mechanisms of Adaptive and Maladaptive Responses of Renal Epithelium to Injury
-
批准号:10265419
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:RAYMOND C. HARRIS
-
依托单位:
Mechanisms of Adaptive and Maladaptive Response of Renal Epithelium to Injury
-
批准号:10483870
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:RAYMOND C. HARRIS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
胃肠安方抑制整合素αvβ6促进胃癌细胞Anoikis防治胃癌转移的机制研究
-
批准号:82305335
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:卢艳琳
-
依托单位:
AMPK通路调控CEMIP诱导自噬对前列腺癌细胞anoikis耐受的影响及机制
-
批准号:81772751
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2017
-
负责人:邢毅飞
-
依托单位:
Myxoma 病毒蛋白Serp-1促进肝癌细胞Anoikis的作用及机制研究
-
批准号:81372597
-
项目类别:面上项目
-
资助金额:16.0万元
-
批准年份:2013
-
负责人:陈昊
-
依托单位:
TrkB/BDNF通路对前列腺癌EMT、anoikis和血管生成的影响及分子机制
-
批准号:81272847
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:邢毅飞
-
依托单位:
E-cadherin调控卵巢癌细胞anoikis-resistance的分子机制及干预
-
批准号:81172487
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:刘联
-
依托单位:
NDRG1在肝癌细胞抵抗Anoikis中的作用及其机制研究
-
批准号:30873025
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2008
-
负责人:曹莉莉
-
依托单位:
肝癌细胞抵抗anoikis关键分子的筛选和鉴定
-
批准号:30700357
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2007
-
负责人:韩丽辉
-
依托单位:
阻遏供体鼠胰岛整合素介导的Anoikis延长移植胰岛存活率
-
批准号:30070724
-
项目类别:面上项目
-
资助金额:15.0万元
-
批准年份:2000
-
负责人:吴育连
-
依托单位: